Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union

NATerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

November 11, 2021

Study Completion Date

January 8, 2023

Conditions
Glaucoma, Open-Angle
Interventions
DEVICE

Beacon Aqueous Microshunt

"The Beacon Aqueous Microshunt is an implantable device designed to lower intraocular pressure (IOP) in glaucoma patients by shunting aqueous humor from the anterior chamber of the eye to the surface of the eye.~Because there are no physiologic sources of outflow resistance, the device can be engineered to target an IOP that is low enough to halt the progression to blindness in a patient suffering from glaucoma."

Trial Locations (2)

23538

Universitatsklinikum Schleswig-Holstein, Lübeck

Unknown

University Eye Hospital, Bochum

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MicroOptx

INDUSTRY

NCT03634319 - Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union | Biotech Hunter | Biotech Hunter